SALT LAKE CITY--(BUSINESS WIRE)--JQ Medical (“the Company”) announced that its board of directors has appointed 15-year Healthcare industry leader Matt Gallagher as its new chief executive officer, which Matt assumed effective February 6, 2023. Gallagher has also joined the JQ Medical board of directors upon assuming the role. Matt succeeded Jon Zalk, who will continue to serve in an advisory capacity to the Company.
Gallagher is a highly respected CEO and industry veteran with more than 15 years of healthcare and leadership experience.
“Matt is a proven healthcare leader with a distinguished track record of market-leading growth, customer service, talent development, and a deep knowledge of the Home Medical Equipment market. He will continue JQ Medical’s legacy of providing a world-class customer experience and industry-leading therapy adherence of its customers managing chronic conditions, while accelerating the Company’s expansion into other markets,” said Matt Komenda, Chairman of the JQ Medical board and Managing Partner of Tacoma Holdings.
“After careful consideration, the board concluded that Matt Gallagher’s deep healthcare background and long and successful track-record as a senior executive made him the right person to lead JQ Medical during this period of rapid expansion. The board is confident that Matt, together with the rest of the leadership team, will continue to deliver on JQ Medical’s mission of helping each of its customers live healthier and longer lives,” said Jeff Henderson, Director of the JQ Medical board and Partner at Tacoma Holdings.
“I am thrilled to join and lead JQ Medical forward at this important time for the Company,” said Gallagher. “Having spent 15 years in the Healthcare industry, and nearly 11 years in the Home Medical Equipment segment, I know how unique it is for a healthcare company to deliver the kind of customer experience for which JQ Medical is well known. JQ Medical’s track record of +90% therapy adherence of its customers on Continuous Glucose Monitor and Insulin Pump therapy is truly world-class and creates an opportunity for the Company to serve a central role in helping people who are managing Type 1 and Type 2 Diabetes achieve meaningfully better health outcomes and live longer and healthier lives. I believe the opportunity in front of the Company is truly exceptional.”
Most recently, Matt served as the Chief Commercial Officer of Breg, a leading non-surgical Orthopedic company. Prior to joining Breg, Matt served as the President and Chief Executive Officer of Falck USA, one of the largest private providers of emergency medical services in the United States. Earlier in his career, Matt spent 10 years at Apria Healthcare, where he served in various roles, including as Regional Vice President over California.
About JQ Medical
Founded in 1994, JQ Medical is a home medical equipment supplier that helps individuals with chronic conditions, particularly those with Type 1 and Type 2 Diabetes, achieve industry-leading health outcomes. Through its uniquely customer-centric operating model, JQ Medical has consistently achieved world-class customer satisfaction (+90 out of 100) and net promoter (+80) scores, while helping to ensure +90% therapy adherence by its customers managing Type 1 or Type 2 Diabetes. JQ Medical is headquartered in Salt Lake City, Utah and serves customers throughout the United States. For more information, please visit: www.jqmedical.com.
About Tacoma Holdings
Founded in 2020, Tacoma Holdings is a private equity firm focused on founder-built healthcare companies in high-growth markets. Tacoma pursues a hyper-thematic and operationally intensive approach to its investments and surrounds its companies with a team of world-class operators at the board of director level. For more information, please visit: www.tacomaholdings.com.
